Health impact, budget impact, and price threshold for cost-effectiveness of lenacapavir for HIV pre-exposure prophylaxis in eastern and southern Africa: a modelling analysisLinxuan Wu, Monisha Sharma, Brian Pfau et al.|The Lancet HIV|2024Cited by 26
Cost thresholds for anticipated long‐acting HIV pre‐exposure prophylaxis products in Eastern and Southern Africa: a mathematical modelling studyDavid Kaftan, Anna Bershteyn, Monisha Sharma et al.|Journal of the International AIDS Society|2025Cited by 10
Health and budget impact, and price threshold for cost-effectiveness of lenacapavir for PrEP in Eastern and Southern Africa: a modeling analysisLinxuan Wu, Monisha Sharma, Rachel Wittenauer et al.|medRxiv|2024Cited by 0